Literature DB >> 27376804

High-density lipoprotein cholesterol and in-hospital mortality in patients with acute aortic dissection.

Xin-Tian Liu1, Xing-Wei He2, Rong Tan1, Wan-Jun Liu1, Bei Wang1, Yu-Jian Liu1, Tao Wang1, Cheng-Wei Liu2, Xi Su2, He-Song Zeng3.   

Abstract

The association between high-density lipoprotein cholesterol (HDL-C) and mortality in patients with acute aortic dissection (AAD) is unclear. From January 2007 to January 2014, a total of 928 consecutive AAD patients who were admitted within 48 h after the onset of symptoms were enrolled in the study. Patients were divided into two groups according to whether serum HDL-C level was below the normal lower limit or not. The Cox proportional hazard regression model was used to identify the predictive value of HDL-C for in-hospital mortality in patients with AAD. As compared with normal HDL-C group (n=585), low HDL-C group (n=343) had lower levels of systolic blood pressure and hemoglobin and higher levels of leukocyte, alanine aminotransferase, blood glucose, blood urea nitrogen, creatinine and urea acid. Low HDL-C group had significantly higher in-hospital mortality than normal HDL-C group (21.6% vs. 12.6%, log-rank=10.869, P=0.001). After adjustment for baseline variables including demographics and biologic data, the increased risk of in-hospital mortality in low HDL-C group was substantially attenuated and showed no significant difference (adjusted hazard ratio, 1.23; 95% confidence interval, 0.86-1.77; P=0.259). Low HDL-C is strongly but not independently associated with in-hospital mortality in patients with AAD.

Entities:  

Keywords:  acute aortic dissection; high-density lipoprotein cholesterol; in-hospital mortality

Mesh:

Substances:

Year:  2016        PMID: 27376804     DOI: 10.1007/s11596-016-1592-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

Review 1.  Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome.

Authors:  Robert S Rosenson; H Bryan Brewer; Daniel J Rader
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

Review 2.  Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type A aortic dissection.

Authors:  Robert S Bonser; Aaron M Ranasinghe; Mahmoud Loubani; Jonathan D Evans; Nassir M A Thalji; Jean E Bachet; Thierry P Carrel; Martin Czerny; Roberto Di Bartolomeo; Martin Grabenwöger; Lars Lonn; Carlos A Mestres; Marc A A M Schepens; Ernst Weigang
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

3.  Relationship of admission neutrophil-to-lymphocyte ratio with in-hospital mortality in patients with acute type I aortic dissection.

Authors:  Gökhan Lafçi; Ömer Faruk Ciçek; Haci Alper Uzun; Adnan Yalçinkaya; Adem İlkay Diken; Osman Turak; Kumral Çağli; İrfan Taşoğlu; Hikmet Selçuk Gedik; Kemal Korkmaz; Orhan Eren Günertem; Kerim Çağali
Journal:  Turk J Med Sci       Date:  2014       Impact factor: 0.973

4.  Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.

Authors:  Roswitha M Wolfram; H Bryan Brewer; Zhenyi Xue; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Am J Cardiol       Date:  2006-07-17       Impact factor: 2.778

Review 5.  Thoracic aortic aneurysm and dissection.

Authors:  Judith Z Goldfinger; Jonathan L Halperin; Michael L Marin; Allan S Stewart; Kim A Eagle; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2014-10-21       Impact factor: 24.094

Review 6.  Nutritional abnormalities contributing to cachexia in chronic illness.

Authors:  Klaus K A Witte; Andrew L Clark
Journal:  Int J Cardiol       Date:  2002-09       Impact factor: 4.164

7.  Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.

Authors:  Poh-Shiow Yeh; Chun-Ming Yang; Sheng-Hsiang Lin; Wei-Ming Wang; Po-Sheng Chen; Ting-Hsing Chao; Huey-Juan Lin; Kao-Chang Lin; Chia-Yu Chang; Tain-Junn Cheng; Yi-Heng Li
Journal:  Atherosclerosis       Date:  2013-04-03       Impact factor: 5.162

8.  Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study.

Authors:  Stephane Arques; Emmanuel Roux; Pascal Sbragia; Richard Gelisse; Bertrand Pieri; Pierre Ambrosi
Journal:  Int J Cardiol       Date:  2007-10-29       Impact factor: 4.164

9.  Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissection.

Authors:  Dan Wen; Xin Du; Jian-Zeng Dong; Xian-Liang Zhou; Chang-Sheng Ma
Journal:  Heart       Date:  2013-06-28       Impact factor: 5.994

10.  Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection.

Authors:  Kenichi Sakakura; Norifumi Kubo; Junya Ako; Hiroshi Wada; Naoki Fujiwara; Hiroshi Funayama; Nahoko Ikeda; Tomohiro Nakamura; Yoshitaka Sugawara; Takanori Yasu; Masanobu Kawakami; Shin-ichi Momomura
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

View more
  3 in total

1.  Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection.

Authors:  Yuchen He; Changcheng Ma; Jia Xing; Shiyue Wang; Chao Ji; Yanshuo Han; Jian Zhang
Journal:  BMC Cardiovasc Disord       Date:  2019-12-03       Impact factor: 2.298

2.  Admission LDL-C and long-term mortality in patients with acute aortic dissection: a survival analysis in China.

Authors:  Xin Zeng; Xuan Zhou; Xue-Rui Tan; Ye-Qun Chen
Journal:  Ann Transl Med       Date:  2021-08

3.  Serum Oxylipin Profiles Identify Potential Biomarkers in Patients with Acute Aortic Dissection.

Authors:  Yi Jiang; Xinlong Tang; Yali Wang; Wei Chen; Yunxing Xue; Hailong Cao; Bomin Zhang; Jun Pan; Qing Zhou; Dongjin Wang; Fudong Fan
Journal:  Metabolites       Date:  2022-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.